Alternative splicing of its 5′-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies
Zhiwei Ang(Children's Hospital of Philadelphia), Andrei Thomas‐Tikhonenko(Children's Hospital of Philadelphia)
Cited by 43
Related Papers
CD19 is a major B cell receptor–independent activator of MYC-driven B-lymphomagenesis
|Journal of Clinical Investigation|2012|95
The short-chain fatty acid receptor GPR43 is transcriptionally regulated by XBP1 in human monocytes
|Scientific Reports|2015|46
Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma
|Leukemia|2019|29
An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia
|Cancer Research|2024|10
MYC hyperactivates WNT signaling in APC/CTNNB1-mutated colorectal cancer cells through miR-92a-dependent repression of DKK3
|bioRxiv (Cold Spring Harbor Laboratory)|2021|0